Cencora has so far notified over a million ... per a list of data breaches published by the U.S. Department of Health and Human Services (HHS). Although the number of affected individuals has ...

Cencora gets a buy rating, agreeing with today's consensus from Wall St. The sector and macro environment point to continued demand for the healthcare supplies and niche specialty drugs Cencora ...

Nov 6 (Reuters) - A federal judge on Monday pared back a U.S. government lawsuit accusing drug distributor Cencora (COR.N), opens new tab, formerly called AmerisourceBergen, of fueling the nation ...

Shareholders might have noticed that Cencora, Inc. (NYSE:COR) filed its quarterly result this time last week. The early response was not positive, with shares down 3.1% to US$283 in the past week.